S&P 500   3,374.00 (-0.18%)
DOW   29,294.26 (-0.35%)
QQQ   234.45 (-0.08%)
AAPL   317.19 (-2.39%)
FB   217.12 (+1.37%)
MSFT   187.50 (+1.16%)
GOOGL   1,522.43 (+0.24%)
AMZN   2,145.76 (+0.51%)
CGC   22.47 (+1.54%)
NVDA   289.18 (-0.21%)
BABA   219.30 (-0.15%)
MU   57.27 (-2.10%)
GE   12.92 (+0.62%)
TSLA   853.77 (+6.72%)
AMD   55.73 (+0.74%)
T   38.16 (-0.24%)
F   8.13 (+0.37%)
PRI   135.98 (-0.63%)
DIS   139.10 (-0.32%)
GILD   67.14 (-0.62%)
S&P 500   3,374.00 (-0.18%)
DOW   29,294.26 (-0.35%)
QQQ   234.45 (-0.08%)
AAPL   317.19 (-2.39%)
FB   217.12 (+1.37%)
MSFT   187.50 (+1.16%)
GOOGL   1,522.43 (+0.24%)
AMZN   2,145.76 (+0.51%)
CGC   22.47 (+1.54%)
NVDA   289.18 (-0.21%)
BABA   219.30 (-0.15%)
MU   57.27 (-2.10%)
GE   12.92 (+0.62%)
TSLA   853.77 (+6.72%)
AMD   55.73 (+0.74%)
T   38.16 (-0.24%)
F   8.13 (+0.37%)
PRI   135.98 (-0.63%)
DIS   139.10 (-0.32%)
GILD   67.14 (-0.62%)
S&P 500   3,374.00 (-0.18%)
DOW   29,294.26 (-0.35%)
QQQ   234.45 (-0.08%)
AAPL   317.19 (-2.39%)
FB   217.12 (+1.37%)
MSFT   187.50 (+1.16%)
GOOGL   1,522.43 (+0.24%)
AMZN   2,145.76 (+0.51%)
CGC   22.47 (+1.54%)
NVDA   289.18 (-0.21%)
BABA   219.30 (-0.15%)
MU   57.27 (-2.10%)
GE   12.92 (+0.62%)
TSLA   853.77 (+6.72%)
AMD   55.73 (+0.74%)
T   38.16 (-0.24%)
F   8.13 (+0.37%)
PRI   135.98 (-0.63%)
DIS   139.10 (-0.32%)
GILD   67.14 (-0.62%)
S&P 500   3,374.00 (-0.18%)
DOW   29,294.26 (-0.35%)
QQQ   234.45 (-0.08%)
AAPL   317.19 (-2.39%)
FB   217.12 (+1.37%)
MSFT   187.50 (+1.16%)
GOOGL   1,522.43 (+0.24%)
AMZN   2,145.76 (+0.51%)
CGC   22.47 (+1.54%)
NVDA   289.18 (-0.21%)
BABA   219.30 (-0.15%)
MU   57.27 (-2.10%)
GE   12.92 (+0.62%)
TSLA   853.77 (+6.72%)
AMD   55.73 (+0.74%)
T   38.16 (-0.24%)
F   8.13 (+0.37%)
PRI   135.98 (-0.63%)
DIS   139.10 (-0.32%)
GILD   67.14 (-0.62%)
Log in

OTCMKTS:ALXA - Alexza Pharmaceuticals Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume100 shs
Average Volume158,340 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Alexza Pharmaceuticals, Inc is a pharmaceutical company focused on the research, development and commercialization of products for the acute treatment of central nervous system conditions. The Company's product candidates are based on the Staccato system technology. Its product candidates in development include AZ-002, which contains alprazolam as an active pharmaceutical ingredient (API) is developed for the management of patients with acute repetitive seizures, and AZ-007, which contains zaleplon as API is developed for the treatment of insomnia in patients who have difficulty falling asleep, including those patients with middle of the night awakening having difficulty falling back asleep. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolOTCMKTS:ALXA
Previous SymbolNASDAQ:ALXA
CUSIPN/A
Phone+1-650-9447000

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive ALXA News and Ratings via Email

Sign-up to receive the latest news and ratings for ALXA and its competitors with MarketBeat's FREE daily newsletter.


Alexza Pharmaceuticals (OTCMKTS:ALXA) Frequently Asked Questions

What is Alexza Pharmaceuticals' stock symbol?

Alexza Pharmaceuticals trades on the OTCMKTS under the ticker symbol "ALXA."

How were Alexza Pharmaceuticals' earnings last quarter?

Alexza Pharmaceuticals, Inc. (OTCMKTS:ALXA) posted its quarterly earnings data on Wednesday, May, 11th. The healthcare company reported ($0.16) earnings per share for the quarter. The healthcare company earned $0.72 million during the quarter. View Alexza Pharmaceuticals' Earnings History.

Has Alexza Pharmaceuticals been receiving favorable news coverage?

Media stories about ALXA stock have been trending neutral on Tuesday, according to InfoTrie. The research group identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Alexza Pharmaceuticals earned a daily sentiment score of 0.4 on InfoTrie's scale. They also assigned media stories about the healthcare company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Alexza Pharmaceuticals.

What other stocks do shareholders of Alexza Pharmaceuticals own?

What is Alexza Pharmaceuticals' official website?

The official website for Alexza Pharmaceuticals is http://www.alexza.com/.

How can I contact Alexza Pharmaceuticals?

Alexza Pharmaceuticals' mailing address is 2091 Stierlin Ct, MOUNTAIN VIEW, CA 94043-4655, United States. The healthcare company can be reached via phone at +1-650-9447000.


MarketBeat Community Rating for Alexza Pharmaceuticals (OTCMKTS ALXA)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  171 (Vote Outperform)
Underperform Votes:  139 (Vote Underperform)
Total Votes:  310
MarketBeat's community ratings are surveys of what our community members think about Alexza Pharmaceuticals and other stocks. Vote "Outperform" if you believe ALXA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALXA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel